RGEN
Repligen Corp
Price:  
169.05 
USD
Volume:  
889,463.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN Relative Valuation

-99.4%
Upside

As of 2026-01-07, the Relative Valuation of Repligen Corp (RGEN) is 1.02 USD. This relative valuation is based on P/E multiples. With the latest stock price at 169.05 USD, the upside of Repligen Corp based on Relative Valuation is -99.4%.

The range of the Relative Valuation is 0.97 - 1.09 USD.

Range Selected
Trailing P/E multiples 32.5x - 35.4x 34.0x
Forward P/E multiples 31.4x - 32.4x 32.1x
Fair Price 0.97 - 1.09 1.02
Upside -99.4% - -99.4% -99.4%
169.05 USD
Stock Price
1.02 USD
Fair Price

RGEN Relative Valuation - Historical P/E Data

Date P/E
2026-01-07 5,475.16
2026-01-06 5,579.12
2026-01-05 5,487.79
2026-01-02 5,322.94
2025-12-31 5,307.07
2025-12-30 5,395.48
2025-12-29 5,367.63
2025-12-26 5,383.18
2025-12-24 5,365.36
2025-12-23 5,388.03
2025-12-22 5,362.77
2025-12-19 5,259.13
2025-12-18 5,108.20
2025-12-17 5,082.29
2025-12-16 5,120.19
2025-12-15 5,200.83
2025-12-12 5,097.52
2025-12-11 5,235.81
2025-12-10 5,305.12
2025-12-09 5,203.75
2025-12-08 5,208.28
2025-12-05 5,343.34
2025-12-04 5,368.60
2025-12-03 5,393.22
2025-12-02 5,344.64
2025-12-01 5,387.71
2025-11-28 5,538.96
2025-11-26 5,544.14
2025-11-25 5,562.93
2025-11-24 5,417.18
2025-11-21 5,263.34
2025-11-20 4,999.38
2025-11-19 5,022.70
2025-11-18 4,957.28
2025-11-17 4,825.78
2025-11-14 4,934.93
2025-11-13 4,876.31
2025-11-12 5,117.60
2025-11-11 4,969.58
2025-11-10 4,717.61
2025-11-07 4,625.63
2025-11-06 4,695.58
2025-11-05 4,723.44
2025-11-04 4,758.74
2025-11-03 4,863.68
2025-10-31 4,827.73
2025-10-30 4,682.30
2025-10-29 4,808.94
2025-10-28 4,909.02
2025-10-27 5,217.67